- Eli Lilly Cuts Q4 Revenue Guidance, Expects Around $5.5 Billion Sales From Weight Loss/Diabetes Drugs, Stock Tanks Yahoo Finance
- Why Eli Lilly (LLY) Stock Is Declining Today Yahoo Finance
- Eli Lilly shares drop as drugmaker cuts revenue guidance on weight loss drug demand CNBC
- Eli Lilly’s stock falls as weight-loss drug sales disappoint MarketWatch
- Lilly forecasts weak fourth-quarter sales of weight-loss drug, shares slump Reuters